ALG9 Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9H6U8 |
---|---|
Other Accession | NP_001071159.1, NP_001071160.1, NP_001071158.1, NP_079016.2 |
Clone Names | 90819099 |
Gene ID | 79796 |
---|---|
Other Names | Alpha-1, 2-mannosyltransferase ALG9, Asparagine-linked glycosylation protein 9 homolog, Disrupted in bipolar disorder protein 1, Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1, 2-mannosyltransferase, Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1, 2-mannosyltransferase, ALG9, DIBD1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | ALG9 (HGNC:15672) |
---|---|
Function | Catalyzes the transfer of mannose from Dol-P-Man to lipid- linked oligosaccharides. |
Cellular Location | Endoplasmic reticulum membrane; Multi-pass membrane protein |
Tissue Location | Ubiquitously expressed; with highest levels in heart, liver and pancreas. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes an alpha-1,2-mannosyltransferase enzymethat functions in lipid-linked oligosaccharide assembly. Mutationsin this gene result in congenital disorder of glycosylation typeIl. Multiple transcript variants encoding different isoforms havebeen found for this gene.
References
Vleugels, W., et al. Glycobiology 19(8):910-917(2009)Baysal, B.E., et al. Behav Brain Funct 2, 25 (2006) :Weinstein, M., et al. Am. J. Med. Genet. A 136(2):194-197(2005)Frank, C.G., et al. Am. J. Hum. Genet. 75(1):146-150(2004)Baysal, B.E., et al. Neurogenetics 4(1):43-53(2002)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.